Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility

References

• Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis. 2012;73(1):45–48. doi:10.1016/j.diagmicrobio.2012.02.00122578938
   PubMed Web of Science ®Google Scholar
• Bajwa S, Kulshrestha A. Fungal infections in intensive care unit: challenges in diagnosis and management. Ann Med Health Sci Res. 2013;3:238. doi:10.4103/2141-9248.11366923919197
   PubMedGoogle Scholar
• Hesstvedt L, Gaustad P, Andersen CT, et al. Twenty-two years of candidaemia surveillance: results from a Norwegian national study. Clin Microbiol Infect. 2015;21:938–945. doi:10.1016/j.cmi.2015.06.00826093076
   PubMed Web of Science ®Google Scholar
• Ericson EL, Klingspor L, Ullberg M, et al. Clinical comparison of the Bactec Mycosis IC/F, BacT/Alert FA, and BacT/Alert FN blood culture vials for the detection of candidemia. Diagn Microbiol Infect Dis. 2012;73:153–156. doi:10.1016/j.diagmicrobio.2012.02.02022494558
   PubMed Web of Science ®Google Scholar
• Zaki SM, Denning DW. Serious fungal infections in Egypt. Eur J Clin Microbiol Infect Dis. 2017;36(6):971–974. doi:10.1007/s10096-017-2929-428213689
   PubMed Web of Science ®Google Scholar
• Chow JK, Golan Y, Ruthazer R, et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis. 2008;46:1206–1213. doi:10.1086/52943518444857
   PubMed Web of Science ®Google Scholar
• Lyon GM, Karatela S, Sunay S. Antifungal susceptibility testing of Candida isolates from the Candida surveillance study. J Clin Microbiol. 2010;48(4):1270–1275. doi:10.1128/JCM.02363-0920129963
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent problem. Clin Microbiol Rev. 2007;20(1):133–163. doi:10.1128/CMR.00029-0617223626
   PubMed Web of Science ®Google Scholar
• BioMérieux product list. 2012 Available from: www.bioMérieux.com. doi:10.1094/PDIS-11-11-0999-PDN. Accessed July 2016.
   Google Scholar
• Oxoid product list. 2012 Available from: www.oxoid.com. doi:10.1094/PDIS-11-11-0999-PDN. Accessed July 2016.
   Google Scholar
• Cheesbrough M. Microbiological tests In: Cheesbrough M, editor. District Laboratory Practice in Tropical Countries. 2nd ed. 2009 Cambridge University Press: Part II, Chapter (7). 1–266.
   Google Scholar
• Lee SC, LO HJ, Fung CP, Lee N, See LC. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole. J Microbiol Immunolo Infect. 2009;42(2):148–153.
   Web of Science ®Google Scholar
• CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2012 (Document M27-S4).
   Google Scholar
• Alastruey-Izquierdo A, Melhem MSC, Bonfietti LX, Rodriguez-Tudela JL. Susceptibility test for fungi: clinical and laboratorial correlations in medical mycology. Rev Inst Med Trop Sao Paulo. 2015;57(19):57–64. doi:10.1590/S0036-46652015000700011
   PubMed Web of Science ®Google Scholar
• Fu J, Ding Y, Wei B, et al. Epidemiology of Candida albicans and non- C. albicans of neonatal candidemia at a tertiary care hospital in western China Journal List. BMC Infect Dis. 2017;17(1):329. doi:10.1186/s12879-017-2757-228477628
   PubMed Web of Science ®Google Scholar
• Hegazi M, Abdelkader A, Zaki M, El-Deek B. Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children’s hospital in Egypt. J Infect Dev Ctries. 2014;8(5):624–634. doi:10.3855/jidc.418624820467
   PubMed Web of Science ®Google Scholar
• Gupta P, Prateek S, Chatterjee B, Kotwal A, Singh AK, Mittal G. Prevalence of candidaemia in ICU in a tertiary care hospital in North India. Int J Curr Microbiol Sci. 2015;4(6):566–575.
   Google Scholar
• Fraimow HS, Tsigrelis C. Antimicrobial resistance in the intensive care unit: mechanisms, epidemiology, and management of specific resistant pathogens. Crit Care Clin. 2011;27(1):163–205. doi:10.1016/j.ccc.2010.11.00221144992
   PubMed Web of Science ®Google Scholar
• Dutta A, Palazzi DL. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J. 2011;30(8):664–668. doi:10.1097/INF.0b013e318213da0f21372750
   PubMed Web of Science ®Google Scholar
• Rajendran RL, Sherry CJ, Nile A, et al. Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection—scotland, 2012–2013. Clin Microbiol Infect. 2016;22(1):87–93. doi:10.1016/j.cmi.2015.09.01826432192
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Fiori B, Trecarichi EM, et al. Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PLoS ONE. 2012;7(3):e33705. doi:10.1371/journal.pone.003370522479431
   PubMedGoogle Scholar
• Furlaneto MC, Rota JF, Quesada RM, et al. Species distribution and in vitro fluconazole susceptibility of clinical Candida isolates in a Brazilian tertiary-care hospital over a 3-year period. Rev Soc Bras Med Trop. 2011;44(5):595–599.22031076
   PubMed Web of Science ®Google Scholar
• Caggiano G, Coretti C, Bartolomeo N, Lovero G, De Giglio O, Montagna MT. Candida bloodstream infections in Italy: changing epidemiology during 16 years of surveillance. Biomed Res Int. 2015;2015:256580. doi:10.1155/2015/25658026064890
   PubMed Web of Science ®Google Scholar
• Capoor MR, Nair D, Deb M, Verma PK, Srivastava L, Aggarwal P. Emergence of non-albicans Candida species and antifungal resistance in tertiary care hospital. Jpn J Infect Dis. 2005;58(6):344–348.16377864
   PubMed Web of Science ®Google Scholar
• Mota AJ, Graziella N, Back-Brito GN, Nobrega FG. Molecular identification of Pichia guilliermondii, Debaryomyceshansenii and Candida palmioleophila. Genet Mol Biol. 2012;35:122–125.22481884
   PubMed Web of Science ®Google Scholar
• Shields RK, Nguyen MH, Clancy CJ. Clinical perspectives on echinocandin resistance among Candida species. Curr Opin Infect Dis. 2015;28(6):514–522. doi:10.1097/QCO.000000000000021526524326
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Díaz-Martín A, García-Cabrera E, et al. Risk factors for fluconazole-resistant candidemia. Antimicrob Agents Chemother. 2010;54:3149–3154. doi:10.1128/AAC.00479-1020498325
   PubMed Web of Science ®Google Scholar
• Liao X, Qiu H, Li R, et al. Risk factors of fluconazole-resistant invasive candidiasis in intensive care unit patients. J Crit Care. 2015;30(4):862e1–862e5.
   Web of Science ®Google Scholar